Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescribed in the primary and secondary prevention of cardiovascular disease, promote apoptosis and limit proliferation of esophageal cancer cell lines. We investigated whether statin use after a diagnosis of esophageal cancer is associated with reduced esophageal cancer-specific and all-cause mortality.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gastroenterology

Title: Gastroenterology

Publisher: Elsevier BV

ISSN (Electronic): 1528-0012

ISSN (Print): 0016-5085

Publication date (Electronic): Apr 2016

Volume: 150

Issue: 4

Affiliations

[1 ] Norwich Medical School, University of East Anglia, Norwich, United Kingdom; Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, United Kingdom. Electronic address: Leo.Alexandre@uea.ac.uk.

[2 ] Norwich Medical School, University of East Anglia, Norwich, United Kingdom.

[3 ] Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, United Kingdom.

[4 ] Norwich Medical School, University of East Anglia, Norwich, United Kingdom; Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, United Kingdom.

Article

Publisher Item ID: S0016-5085(16)00003-2

DOI: 10.1053/j.gastro.2015.12.039

PubMed ID: 26775632

SO-VID: 2b393668-57f3-44a9-bcea-bd0d73c5440f

History

Keywords: HMG-CoA,CPRD,Esophagus,Pleiotropy

Data availability:

Keywords: HMG-CoA, CPRD, Esophagus, Pleiotropy

Comments

Comment on this article

scite_

Cited by 15

See all cited by